In vivo trials highlight the role of TLR3 in upper airway allergic diseases, demonstrating that seasonal allergic rhinitis exacerbated by pollen exposure increases TLR3 mRNA expression and immunoreactivity in the nasal mucosa [130]. This evidence concerns the gene TLR3 and allergic rhinitis.